de Vries A - Search Results

1

Therapeutic drug monitoring of anti-TNF drugs: an overview of applicability in daily clinical practice in the era of treatment with biologics in juvenile idiopathic arthritis (JIA).

Nassar-Sheikh Rashid A, Schonenberg-Meinema D, Bergkamp SC, Bakhlakh S, de Vries A, Rispens T, Kuijpers TW, Wolbink G, van den Berg JM. Nassar-Sheikh Rashid A, et al. Among authors: de vries a. Pediatr Rheumatol Online J. 2021 Apr 29;19(1):59. doi: 10.1186/s12969-021-00545-x. Pediatr Rheumatol Online J. 2021. PMID: 33926495 Free PMC article.

2

Serum tocilizumab trough concentration can be used to monitor systemic IL-6 receptor blockade in patients with rheumatoid arthritis: a prospective observational cohort study.

Kneepkens EL, van den Oever I, Plasencia CH, Pascual-Salcedo D, de Vries A, Hart M, Nurmohamed MT, Balsa A, Rispens T, Wolbink G. Kneepkens EL, et al. Among authors: de vries a. Scand J Rheumatol. 2017 Mar;46(2):87-94. doi: 10.1080/03009742.2016.1183039. Epub 2016 Jul 20. Scand J Rheumatol. 2017. PMID: 27440258

3

From natalizumab to fingolimod in eight weeks - Immunological, clinical, and radiological data in quest of the optimal switch.

Harrer A, Pilz G, Oppermann K, Sageder M, Afazel S, Haschke-Becher E, Rispens T, de Vries A, McCoy M, Stevanovic V, Hitzl W, Trinka E, Kraus J, Sellner J, Wipfler P. Harrer A, et al. Among authors: de vries a. Clin Immunol. 2017 Mar;176:87-93. doi: 10.1016/j.clim.2017.01.001. Epub 2017 Jan 17. Clin Immunol. 2017. PMID: 28108364

4

The majority of natalizumab-treated MS patients have high natalizumab concentrations at time of re-dosing.

van Kempen ZL, Leurs CE, Witte BI, de Vries A, Wattjes MP, Rispens T, Killestein J. van Kempen ZL, et al. Among authors: de vries a. Mult Scler. 2018 May;24(6):805-810. doi: 10.1177/1352458517708464. Epub 2017 May 9. Mult Scler. 2018. PMID: 28485678 Free PMC article.

5

John Cunningham virus conversion in relation to natalizumab concentration in multiple sclerosis patients.

van Kempen ZLE, Leurs CE, de Vries A, Vennegoor A, Rispens T, Wattjes MP, Killestein J. van Kempen ZLE, et al. Among authors: de vries a. Eur J Neurol. 2017 Sep;24(9):1196-1199. doi: 10.1111/ene.13355. Epub 2017 Jul 14. Eur J Neurol. 2017. PMID: 28707781

6

Dried blood spots from finger prick facilitate therapeutic drug monitoring of adalimumab and anti-adalimumab in patients with inflammatory diseases.

Kneepkens EL, Pouw MF, Wolbink GJ, Schaap T, Nurmohamed MT, de Vries A, Rispens T, Bloem K. Kneepkens EL, et al. Among authors: de vries a. Br J Clin Pharmacol. 2017 Nov;83(11):2474-2484. doi: 10.1111/bcp.13371. Epub 2017 Aug 22. Br J Clin Pharmacol. 2017. PMID: 28791718 Free PMC article.

7

Dried blood samples can support monitoring of infliximab concentrations in patients with inflammatory bowel disease: A clinical validation.

Berends SE, D'Haens GRAM, Schaap T, de Vries A, Rispens T, Bloem K, Mathôt RAA. Berends SE, et al. Among authors: de vries a. Br J Clin Pharmacol. 2019 Jul;85(7):1544-1551. doi: 10.1111/bcp.13939. Epub 2019 May 11. Br J Clin Pharmacol. 2019. PMID: 30927375 Free PMC article.

8

Antidrug antibody detection for adalimumab depends on the type of assay used: an experimental approach to help clinicians interpret diagnostic data.

Ruwaard J, Marsman AF, Nurmohamed MT, van der Horst-Bruinsma IE, Te Velthuis H, Bloem K, de Vries A, Rispens T, Wolbink G. Ruwaard J, et al. Among authors: de vries a. Clin Exp Rheumatol. 2019 Sep-Oct;37(5):756-761. Epub 2019 Mar 18. Clin Exp Rheumatol. 2019. PMID: 30943139 Free article.

9

Anti-natalizumab antibodies during 8 years of natalizumab treatment: effect on natalizumab concentration and α4-integrin receptor saturation.

van Kempen ZLE, van Rossum JA, Doesburg D, Claessen I, de Vries A, Ten Brinke A, van Oosten BW, Rispens T, Killestein J. van Kempen ZLE, et al. Among authors: de vries a. J Neurol. 2019 Jul;266(7):1804-1805. doi: 10.1007/s00415-019-09327-8. Epub 2019 Apr 19. J Neurol. 2019. PMID: 31004214 No abstract available.

10

Vedolizumab Induces Endoscopic and Histologic Remission in Patients With Crohn's Disease.

Löwenberg M, Vermeire S, Mostafavi N, Hoentjen F, Franchimont D, Bossuyt P, Hindryckx P, Rispens T, de Vries A, van der Woude CJ, Berends S, Ambarus CA, Mathot R, Clasquin E, Baert F, D'Haens G. Löwenberg M, et al. Among authors: de vries a. Gastroenterology. 2019 Oct;157(4):997-1006.e6. doi: 10.1053/j.gastro.2019.05.067. Epub 2019 Jun 5. Gastroenterology. 2019. PMID: 31175865

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

2,102 results

Search Page